JNJ Johnson & Johnson
- Stocks
- Healthcare
- NYSE: JNJ
Price (delayed)
$186
Market cap
$448.13B
P/E Ratio
17.83
Dividend/share
$5.08
EPS
$10.43
Enterprise value
$475.69B
Relative Growth:
72
Relative Strength:
69
Relative Valuation:
74
Relative Profitability:
98
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones
Highlights
The EPS has soared by 73% YoY and by 11% from the previous quarter
Johnson & Johnson's net income has surged by 71% YoY and by 11% QoQ
Johnson & Johnson's debt has increased by 28% YoY but it has decreased by 10% from the previous quarter
Key stats
What are the main financial stats of JNJ
Market
Valuations
Earnings
Shares outstanding
2.41B
Market cap
$448.13B
Enterprise value
$475.69B
Price to earnings (P/E)
17.83
Price to book (P/B)
5.65
Price to sales (P/S)
4.86
PEG
0.24
EV/EBIT
14.68
EV/EBITDA
11.96
EV/Sales
5.16
Revenue
$92.15B
Gross profit
$62.73B
Operating income
$23.44B
Net income
$25.12B
EBIT
$32.4B
EBITDA
$39.78B
Free cash flow
$19.6B
Per share
Balance sheet
Liquidity
EPS
$10.43
EPS diluted
$10.35
Free cash flow per share
$8.14
Book value per share
$32.92
Revenue per share
$38.28
TBVPS
$39.89
Total assets
$192.82B
Total liabilities
$113.54B
Debt
$45.8B
Equity
$79.28B
Working capital
$3.74B
Debt to equity
0.58
Current ratio
1.07
Quick ratio
0.71
Net debt/EBITDA
0.69
Margins
Efficiency
Dividend
EBITDA margin
43.2%
Gross margin
68.1%
Net margin
27.3%
Operating margin
25.4%
Return on assets
13.2%
Return on equity
32.7%
Return on invested capital
47%
Return on capital employed
22.8%
Return on sales
35.2%
Dividend yield
2.73%
DPS
$5.08
Payout ratio
48.7%
JNJ stock price
How has the Johnson & Johnson stock price performed over time
Intraday
-0.46%
1 week
-0.32%
1 month
-1.4%
1 year
17.46%
YTD
28.61%
QTD
0.31%
Financial performance
How have Johnson & Johnson's revenue and profit performed over time
Revenue
$92.15B
Gross profit
$62.73B
Operating income
$23.44B
Net income
$25.12B
Gross margin
68.1%
Net margin
27.3%
Johnson & Johnson's net income has surged by 71% YoY and by 11% QoQ
Johnson & Johnson's net margin has soared by 63% YoY and by 9% from the previous quarter
The operating income rose by 9% year-on-year and by 9% since the previous quarter
Johnson & Johnson's operating margin has increased by 7% from the previous quarter and by 4.1% YoY
Price vs fundamentals
How does JNJ's price correlate with its fundamentals
Growth
What is Johnson & Johnson's growth rate over time
Valuation
What is Johnson & Johnson stock price valuation
P/E
17.83
P/B
5.65
P/S
4.86
EV/EBIT
14.68
EV/EBITDA
11.96
EV/Sales
5.16
The EPS has soared by 73% YoY and by 11% from the previous quarter
JNJ's price to earnings (P/E) is 18% lower than its 5-year quarterly average of 21.8 and 7% lower than its last 4 quarters average of 19.1
JNJ's price to book (P/B) is 13% more than its last 4 quarters average of 5.0
JNJ's equity is up by 13% year-on-year
The price to sales (P/S) is 13% more than the last 4 quarters average of 4.3 but 2.8% less than the 5-year quarterly average of 5.0
JNJ's revenue is up by 5% year-on-year
Efficiency
How efficient is Johnson & Johnson business performance
The ROS has soared by 68% YoY and by 13% from the previous quarter
The return on assets has surged by 57% year-on-year and by 8% since the previous quarter
The company's return on equity has surged by 56% YoY and by 8% QoQ
Johnson & Johnson's return on invested capital has surged by 52% YoY and by 9% QoQ
Dividends
What is JNJ's dividend history
DPS
$5.08
Dividend yield
2.73%
Payout ratio
48.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Johnson & Johnson financials performed over time
JNJ's total assets is 70% greater than its total liabilities
JNJ's total assets is up by 8% year-on-year
JNJ's current ratio is up by 6% since the previous quarter and by 3.9% year-on-year
Johnson & Johnson's debt is 42% less than its equity
Johnson & Johnson's debt has increased by 28% YoY but it has decreased by 10% from the previous quarter
The company's debt to equity rose by 14% YoY but it fell by 11% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.